Marios Giannakis
@GiannakisLab
Followers
248
Following
0
Media
1
Statuses
13
Associate Professor of Medicine | @DanaFarber @broadinstitute @harvardmed | Views mine
Joined May 2019
Dr. Kimmie Ng says researchers are evaluating a range of factors that could be fueling a rise in colon cancer, everything from a lack of vitamin D, to the complicated role of the microbiome. CC: @KimmieNgMD @DFarberYoungCRC @NPR
https://t.co/fVn05HR8E8
0
8
23
1/4 New Perspectives piece from Marios Giannakis and @KimmieNgMD of team OPTIMISTICC in @ScienceMagazine discusses the rising global incidence of early-onset colorectal cancer (EOCRC)
science.org
The etiology of early-onset colorectal cancer needs to be understood to tackle rising incidence
1
9
36
I’m on the @ScienceMagazine weekly podcast to talk about the Perspective piece that @GiannakisLab and I wrote on #YoungOnsetColorectalCancer. Tune in to the conversation by clicking below! @DFarberYoungCRC @DanaFarber @DanaFarberNews
On this week's #SciencePodcast🎙️ with @boron110, @KimmieNgMD, and @voooos: ▶️ An active volcano on Venus ▶️ A concerning rise in early onset colon cancer 🎧 Listen here: https://t.co/Ky6nmp3eJ7
1
9
34
Must-read perspective by @GiannakisLab & @KimmieNgMD on the ongoing epidemic of early-onset colorectal cancer diagnoses. Reasons likely complex/multi factorial, in need of deep investigation in order to revert this concerning phenomenon. https://t.co/uePCF9zire
science.org
The etiology of early-onset colorectal cancer needs to be understood to tackle rising incidence
Why are so many young people getting colon cancer? https://t.co/fcADufmq22
@ScienceMagazine w/ @ScienceVisuals by @GiannakisLab @KimmieNgMD @DFarberYoungCRC @DanaFarber
1
5
15
Young-onset #ColorectalCancer: A common cancer at an uncommon age. Publishing online in @ScienceMagazine, @DanaFarber's @KimmieNgMD and @GiannakisLab chart a course to better understand, prevent, and treat the disease. Read: https://t.co/vxhNTr5wAb CC: @DFarberYoungCRC
0
5
5
Read more in the @ASCOPost on research into the effectiveness of a molecular tumor board in precision oncology for patients with gastrointestinal cancer treated at the Dana-Farber Brigham Cancer Center. CC: @DFarberYoungCRC @GiannakisLab Read more ➡️
ascopost.com
The field of precision oncology has become so complex that even experienced oncologists can find it challenging to decipher the molecular test results of tumor tissue and navigate treatment options...
0
2
6
New #ColorectalCancer research from #AACRcrc22 shows an oncogenic role and therapeutic options for one of the most frequent colorectal cancer mutations: RNF43 G659fs. Research presented by Dana-Farber's Marios Giannakis, MD, PhD (@GiannakisLab)
0
3
17
Excited to share our latest research showing an oncogenic role and therapeutic options for one of the most frequent Colorectal Cancer mutations @GiannakisLab @DanaFarber @broadinstitute
https://t.co/yzul41hRBU
4
30
130
We are excited to share our study on spatially organized multicellular immune hubs in human colorectal cancer https://t.co/tzJxdLaLTn
@CellCellPress. Joint effort with @karin_pelka, @chenchirps, @AnaAndersonlab, Orit Rozenblatt-Rosen, Aviv Regev, Nir Hacohen, many others!
2
67
164
Red meat and cancer 🥩 New research led by Dana-Farber's Marios Giannakis, MD, PhD, finds high red meat consumption may promote DNA damage-associated mutations in patients with #colorectalcancer, published in @CD_AACR: https://t.co/ID3QFrWJOg cc @DFarberYoungCRC
1
19
35
New research in @NatureComms: Resistance to immune checkpoint blocker drug linked to metabolic imbalance https://t.co/xuegSkpPJD
#KidneyCancer #Melanoma @DrChoueiri @GiannakisLab
0
14
25
Our work on immune-checkpoint inhibitor resistance in mismatch-repair deficient cancers may offer clues to new immunotherapy strategies in colorectal cancer https://t.co/ka4PkSXiyG
0
0
3